Poland· PL-100334494

Montelukast Medreg

A montelukast product containing montelukastum, registered in Poland by Medreg s.r.o.. The same ATC class is registered in 19 of our 19 countries.

ATC R03DC03

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about montelukastumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Montelukast is registered in 19 of 19 countries.

Countries holding a registration under ATC R03DC03 (montelukast), each read from that country’s own register.

This record: Poland, from URPL (Poland)
11 of them publish a price we can compare per daily dose

Search montelukast products by name

Montelukast · ATC R03DC03

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of montelukast costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in Italy to $1.71 in Spain — a ×2.9 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Montelukast · price per daily dose (10 mg)

USD · FX 28 Sept 2026

ES Spain$1.71
CH Switzerland$1.41
FR France$0.71
IT Italy$0.59

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Montelukastum
Manufacturer: Medreg s.r.o.
Country: Poland (PL)
ATC code: R03DC03
ATC class: Montelukast
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 20

1 priced

gtin
05909991329235
28 szt.
PLN 22.55
gtin
05909991329358
gtin
05909991329365
gtin
05909991329372
gtin
05909991329389
gtin
05909991329396
gtin
05909991329204
gtin
05909991329211
gtin
05909991329228
gtin
05909991329242
gtin
05909991329259
gtin
05909991329266
gtin
05909991329273
gtin
05909991329280
gtin
05909991329297
gtin
05909991329303
gtin
05909991329310
gtin
05909991329327
gtin
05909991329334
gtin
05909991329341

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

565 interactions on record for montelukast.

Graded by severity as the source publishes them — 101 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check montelukast against other medicines How interaction checks work

Montelukast · interactions on record

565 records

101 moderate
464 info

Most severe, free to view

MiconazoleA07AC01moderate
TroglitazoneA10BG01moderate
NateglinideA10BX03moderate
NitisinoneA16AX04moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Montelukast in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All montelukast products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Lanair, Montelukast +pharma
Belgium · Montelukast Ab, Montelukast Eg
Bulgaria · Eфира, Moнтелукаст Акорд
Cyprus · Modulair, Montelukast Krka
Czechia · Castispir, Monkasta
Germany · Monkasta, Montelair Hexal
Denmark · Montelukast "sandoz", Montelukast Accord Healthcare
Estonia · Monkasta, Montelukast Teva
Spain · Monkasta, Montelukast Accord
Finland · Montelukast, Montelukast Accord
France · Montelukast Accord, Montelukast Accord Healthcare
United Kingdom (Northern Ireland) · Montelukast, Montelukast for Children From 6 To 14 Years Accord Healthcare
Greece · Apilone, Ascolin
Croatia · Melarth, Monkasta
Hungary · Eonic, Monalux
Ireland · Montelair, Montelukast
Iceland · Montelukast Alvogen, Singulair
Italy · Aleast Per Bambini Da 2 A 5 Anni, Aleast Per Bambini Da 6 A 14 Anni
Lithuania · Monkasta
Luxembourg · Montelukast Eurogenerics, Montelukast Ratiopharm
Latvia · Monkasta
Malta · Actamone, Monkasta
Netherlands · Montelukast Accord, Montelukast Amarox
Norway · Montelukast Krka, Montelukast Sandoz
Portugal · Montelucaste Accord, Montelucaste Alter
Romania · Monkasta, Montelukast Arena
Sweden · Montelukast Accord, Montelukast Amarox
Slovenia · Monkasta, Singulair
Slovakia · Astmasan, Belokast

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bc98c9bc-34c5-43b0-a9b9-8627551708ac
GET /v1/drugs/bc98c9bc-34c5-43b0-a9b9-8627551708ac?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909991329204 ¦ Rp ¦ 121905\n7 tabl.\n05909991329211 ¦ Rp ¦ 121906\n14 tabl.\n05909991329228 ¦ Rp ¦ 121907\n20 tabl.\n05909991329235 ¦ Rp ¦ 121908\n28 tabl.\n05909991329242 ¦ Rp ¦ 121909\n30 tabl.\n05909991329259 ¦ Rp ¦ 121910\n40 tabl.\n05909991329266 ¦ Rp ¦ 121911\n49 tabl.\n05909991329273 ¦ Rp ¦ 121912\n50 tabl.\n05909991329280 ¦ Rp ¦ 121913\n56 tabl.\n05909991329297 ¦ Rp ¦ 121914\n60 tabl.\n05909991329303 ¦ Rp ¦ 121915\n70 tabl.\n05909991329310 ¦ Rp ¦ 121916\n80 tabl.\n05909991329327 ¦ Rp ¦ 121917\n84 tabl.\n05909991329334 ¦ Rp ¦ 121918\n90 tabl.\n05909991329341 ¦ Rp ¦ 121919\n98 tabl.\n05909991329358 ¦ Rp ¦ 121920\n100 tabl.\n05909991329365 ¦ Rp ¦ 121921\n120 tabl.\n05909991329372 ¦ Rp ¦ 121922\n140 tabl.\n05909991329389 ¦ Rp ¦ 121923\n200 tabl.\n05909991329396 ¦ Rp ¦ 121927\n10 tabl.",
  "substance": "Montelukastum 10 mg",
  "common_name": "Montelukastum",
  "pl_product_id": "100334494",
  "pozwolenie_nr": "24080",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about montelukast.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console